ArticleHeliyon2024
An explainable Artificial Intelligence software system for predicting diabetes.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- A Summary of Cardiometabolic Disorders in the Maghreb: Insights from the 2025 Saclay Cardiometabolic Summit.Cardiology and therapy · 2026Review
- Nutrigenomics meets multi-omics: integrating genetic, metabolic, and microbiome data for personalized nutrition strategies.Genes & nutrition · 2025Review
- My diabetes care: an AI-based mobile app with conversational agent for type 2 diabetes self-management.Scientific reports · 2025Article
- AI-RiskX: An Explainable Deep Learning Approach for Identifying At-Risk Patients During Pandemics.Bioengineering (Basel, Switzerland) · 2025Article
- Artificial Intelligence Enabled Lifestyle Medicine in Diabetes Care: A Narrative Review.American journal of lifestyle medicine · 2025Review
- AI driven network pharmacology: Multi-scale mechanisms of traditional Chinese medicine from molecular to patient analysis.Computational and structural biotechnology journal · 2025Review
- Artificial intelligence applied to diabetes complications: a bibliometric analysis.Frontiers in artificial intelligence · 2025Article
- Federated multimodal AI for precision-equitable diabetes care.Frontiers in digital health · 2025Review
- Identification of sweetpotato virus disease-infected leaves from field images using deep learning.Frontiers in plant science · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Implementing diabetes surveillance systems is paramount to mitigate the risk of incurring substantial medical expenses. Currently, blood glucose is measured by minimally invasive methods, which involve extracting a small blood sample and transmitting it to a blood glucose meter. This method is deemed discomforting for individuals who are undergoing it. The present study introduces an Explainable Artificial Intelligence (XAI) system, which aims to create an intelligible machine capable of explaining expected outcomes and decision models. To this end, we analyze abnormal glucose levels by utilizing Bi-directional Long Short-Term Memory (Bi-LSTM) and Convolutional Neural Network (CNN). In this regard, the glucose levels are acquired through the glucose oxidase (GOD) strips placed over the human body. Later, the signal data is converted to the spectrogram images, classified as low glucose, average glucose, and abnormal glucose levels. The labeled spectrogram images are then used to train the individualized monitoring model. The proposed XAI model to track real-time glucose levels uses the XAI-driven architecture in its feature processing. The model's effectiveness is evaluated by analyzing the performance of the proposed model and several evolutionary metrics used in the confusion matrix. The data revealed in the study demonstrate that the proposed model effectively identifies individuals with elevated glucose levels.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.